ARCELLX INC Financials
This page shows ARCELLX INC (ACLX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Arcellx still runs as a cash-funded development platform, with revenue too episodic to support its cost base.
FY2023's positive operating cash flow of$207.6M did not mark self-funding operations, because revenue was only$110.3M and the company still reported a sizable net loss. When revenue fell to$22.3M in FY2025, operating cash flow reverted to-$210.3M , showing that the earlier cash conversion came from a temporary source rather than from sales covering the cost base.
The FY2025 current ratio of 4.4x suggests short-term liquidity, but it sat beside only
In the latest year, R&D spending reached
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of ARCELLX INC's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
ARCELLX INC scores 17.72, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($6.7B) relative to total liabilities ($201.6M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
ARCELLX INC passes 1 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.
For every $1 of reported earnings, ARCELLX INC generates $0.92 in operating cash flow (-$210.3M OCF vs -$228.9M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Earnings & Revenue
ARCELLX INC generated $22.3M in revenue in fiscal year 2025. This represents a decrease of 79.4% from the prior year.
ARCELLX INC's EBITDA was -$246.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 86.1% from the prior year.
ARCELLX INC reported -$228.9M in net income in fiscal year 2025. This represents a decrease of 113.3% from the prior year.
ARCELLX INC earned $-4.07 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 103.5% from the prior year.
Cash & Balance Sheet
ARCELLX INC generated -$212.6M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 119.4% from the prior year.
ARCELLX INC held $80.3M in cash against $0 in long-term debt as of fiscal year 2025.
ARCELLX INC had 58M shares outstanding in fiscal year 2025. This represents an increase of 6.7% from the prior year.
Margins & Returns
ARCELLX INC's operating margin was -1135.6% in fiscal year 2025, reflecting core business profitability. This is down 1008.1 percentage points from the prior year.
ARCELLX INC's net profit margin was -1027.3% in fiscal year 2025, showing the share of revenue converted to profit. This is down 927.8 percentage points from the prior year.
ARCELLX INC's ROE was -56.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 33.3 percentage points from the prior year.
Capital Allocation
ARCELLX INC invested $157.6M in research and development in fiscal year 2025. This represents an increase of 0.3% from the prior year.
ARCELLX INC invested $2.3M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 82.7% from the prior year.
ACLX Income Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.7M-66.6% | $4.9M-34.5% | $7.6M-7.1% | $8.1M-46.8% | $15.3M-41.4% | $26.0M-4.9% | $27.4M-30.2% | $39.3M |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | $34.1M-2.8% | $35.1M-6.7% | $37.6M-25.9% | $50.8M+13.8% | $44.6M+14.0% | $39.2M-4.3% | $41.0M+26.7% | $32.3M |
| SG&A Expenses | $31.2M-1.2% | $31.6M+10.4% | $28.7M+9.3% | $26.2M+10.3% | $23.8M+16.1% | $20.5M-4.4% | $21.4M-5.8% | $22.7M |
| Operating Income | -$63.7M-3.1% | -$61.8M-5.2% | -$58.7M+14.8% | -$68.9M-29.6% | -$53.2M-58.1% | -$33.6M+3.9% | -$35.0M-121.3% | -$15.8M |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | $40K | $0-100.0% | $29K | $0-100.0% | $1.5M+574.9% | $223K-34.6% | $341K | $0 |
| Net Income | -$58.1M-4.2% | -$55.8M-5.7% | -$52.8M+15.3% | -$62.3M-32.3% | -$47.1M-82.0% | -$25.9M+4.9% | -$27.2M-277.9% | -$7.2M |
| EPS (Diluted) | N/A | $-0.99-5.3% | $-0.94+16.8% | $-1.13 | N/A | $-0.48+5.9% | $-0.51-264.3% | $-0.14 |
ACLX Balance Sheet
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $604.0M-7.9% | $655.9M+5.9% | $619.1M-4.5% | $648.1M-8.9% | $711.3M-7.0% | $764.9M+4.2% | $734.3M-5.8% | $779.7M |
| Current Assets | $462.2M-2.1% | $472.1M+1.8% | $463.9M-16.3% | $554.2M-7.5% | $599.3M+2.0% | $587.3M+10.8% | $530.2M-9.9% | $588.7M |
| Cash & Equivalents | $80.3M+1.6% | $79.0M+26.7% | $62.3M-22.9% | $80.9M-23.5% | $105.7M-34.7% | $161.8M+61.8% | $100.0M-35.3% | $154.6M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $201.6M-6.3% | $215.1M-5.2% | $226.9M-1.9% | $231.2M-9.9% | $256.5M-9.0% | $281.9M+14.1% | $247.1M-12.7% | $283.1M |
| Current Liabilities | $104.2M-12.0% | $118.4M-2.8% | $121.8M+8.3% | $112.5M-10.3% | $125.4M-8.5% | $137.0M+55.2% | $88.3M-18.2% | $107.9M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $402.4M-8.7% | $440.8M+12.4% | $392.2M-5.9% | $416.9M-8.3% | $454.8M-5.8% | $483.0M-0.9% | $487.2M-1.9% | $496.6M |
| Retained Earnings | -$725.8M-8.7% | -$667.6M-9.1% | -$611.9M-9.4% | -$559.1M-12.5% | -$496.8M-10.5% | -$449.7M-6.1% | -$423.9M-6.9% | -$396.7M |
ACLX Cash Flow Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$58.2M-18.2% | -$49.2M-23.9% | -$39.7M+37.1% | -$63.1M-37.2% | -$46.0M-249.8% | $30.7M+184.7% | -$36.2M-13.6% | -$31.9M |
| Capital Expenditures | $764K+158.1% | $296K-39.2% | $487K-37.6% | $780K-48.0% | $1.5M-34.5% | $2.3M-28.7% | $3.2M-50.0% | $6.4M |
| Free Cash Flow | -$58.9M-19.1% | -$49.5M-23.1% | -$40.2M+37.1% | -$63.9M-34.5% | -$47.5M-267.2% | $28.4M+172.0% | -$39.5M-2.9% | -$38.3M |
| Investing Cash Flow | $57.8M+388.6% | -$20.0M-286.4% | $10.7M-71.6% | $37.8M+1017.1% | -$4.1M-111.5% | $35.8M+554.2% | -$7.9M+96.2% | -$206.8M |
| Financing Cash Flow | $1.6M-98.1% | $86.1M+739.4% | $10.3M+1789.0% | $543K+109.0% | -$6.0M-29.2% | -$4.7M+55.3% | -$10.4M-249.3% | -$3.0M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
ACLX Financial Ratios
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | -3850.2%-2602.0pp | -1248.3%-470.8pp | -777.4%+70.1pp | -847.6%-499.4pp | -348.2%-219.0pp | -129.1%-1.4pp | -127.8%-87.5pp | -40.3% |
| Net Margin | -3513.4%-2386.3pp | -1127.1%-428.5pp | -698.6%+67.4pp | -766.0%-457.6pp | -308.4%-209.0pp | -99.4%-0.0pp | -99.3%-81.0pp | -18.3% |
| Return on Equity | -14.4%-1.8pp | -12.7%+0.8pp | -13.5%+1.5pp | -14.9%-4.6pp | -10.4%-5.0pp | -5.4%+0.2pp | -5.6%-4.1pp | -1.5% |
| Return on Assets | -9.6%-1.1pp | -8.5%+0.0pp | -8.5%+1.1pp | -9.6%-3.0pp | -6.6%-3.2pp | -3.4%+0.3pp | -3.7%-2.8pp | -0.9% |
| Current Ratio | 4.44+0.4 | 3.99+0.2 | 3.81-1.1 | 4.93+0.1 | 4.78+0.5 | 4.29-1.7 | 6.01+0.5 | 5.46 |
| Debt-to-Equity | 0.50+0.0 | 0.49-0.1 | 0.58+0.0 | 0.550.0 | 0.56-0.0 | 0.58+0.1 | 0.51-0.1 | 0.57 |
| FCF Margin | -3563.4%-2563.2pp | -1000.3%-467.8pp | -532.4%+254.0pp | -786.4%-475.0pp | -311.3%-420.6pp | 109.2%+253.3pp | -144.1%-46.5pp | -97.7% |
Similar Companies
Frequently Asked Questions
What is ARCELLX INC's annual revenue?
ARCELLX INC (ACLX) reported $22.3M in total revenue for fiscal year 2025. This represents a -79.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is ARCELLX INC's revenue growing?
ARCELLX INC (ACLX) revenue declined by 79.4% year-over-year, from $107.9M to $22.3M in fiscal year 2025.
Is ARCELLX INC profitable?
No, ARCELLX INC (ACLX) reported a net income of -$228.9M in fiscal year 2025, with a net profit margin of -1027.3%.
What is ARCELLX INC's EBITDA?
ARCELLX INC (ACLX) had EBITDA of -$246.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is ARCELLX INC's operating margin?
ARCELLX INC (ACLX) had an operating margin of -1135.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is ARCELLX INC's net profit margin?
ARCELLX INC (ACLX) had a net profit margin of -1027.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is ARCELLX INC's return on equity (ROE)?
ARCELLX INC (ACLX) has a return on equity of -56.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is ARCELLX INC's free cash flow?
ARCELLX INC (ACLX) generated -$212.6M in free cash flow during fiscal year 2025. This represents a -119.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is ARCELLX INC's operating cash flow?
ARCELLX INC (ACLX) generated -$210.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are ARCELLX INC's total assets?
ARCELLX INC (ACLX) had $604.0M in total assets as of fiscal year 2025, including both current and long-term assets.
What are ARCELLX INC's capital expenditures?
ARCELLX INC (ACLX) invested $2.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does ARCELLX INC spend on research and development?
ARCELLX INC (ACLX) invested $157.6M in research and development during fiscal year 2025.
What is ARCELLX INC's current ratio?
ARCELLX INC (ACLX) had a current ratio of 4.44 as of fiscal year 2025, which is generally considered healthy.
What is ARCELLX INC's debt-to-equity ratio?
ARCELLX INC (ACLX) had a debt-to-equity ratio of 0.50 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is ARCELLX INC's return on assets (ROA)?
ARCELLX INC (ACLX) had a return on assets of -37.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is ARCELLX INC's cash runway?
Based on fiscal year 2025 data, ARCELLX INC (ACLX) had $80.3M in cash against an annual operating cash burn of $210.3M. This gives an estimated cash runway of approximately 5 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is ARCELLX INC's Altman Z-Score?
ARCELLX INC (ACLX) has an Altman Z-Score of 17.72, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is ARCELLX INC's Piotroski F-Score?
ARCELLX INC (ACLX) has a Piotroski F-Score of 1 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are ARCELLX INC's earnings high quality?
ARCELLX INC (ACLX) has an earnings quality ratio of 0.92x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is ARCELLX INC?
ARCELLX INC (ACLX) scores 37 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.